• LAST PRICE
    5.9500
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (3.1196%)
  • Bid / Lots
    5.8000/ 2
  • Ask / Lots
    5.9000/ 2
  • Open / Previous Close
    5.7900 / 5.7700
  • Day Range
    Low 5.6700
    High 5.9950
  • 52 Week Range
    Low 2.1300
    High 12.7900
  • Volume
    364,508
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 5.77
TimeVolumeMGNX
09:32 ET13355.79
09:35 ET92695.67
09:37 ET11005.695
09:39 ET4835.69
09:44 ET2005.715
09:46 ET36735.78
09:48 ET16955.7801
09:50 ET1105.785
09:51 ET9505.8059
09:55 ET1005.83
09:57 ET2005.8
10:02 ET2105.83
10:04 ET1005.81
10:06 ET1005.81
10:08 ET1005.805
10:09 ET1005.805
10:11 ET10235.81
10:13 ET1405.799
10:15 ET5675.77
10:18 ET3005.7655
10:22 ET2005.785
10:24 ET11005.76
10:31 ET22085.82
10:33 ET2005.835
10:36 ET1005.81
10:38 ET20955.815
10:40 ET20005.78
10:42 ET8215.81
10:44 ET1005.79
10:45 ET6005.76
10:47 ET2005.74
10:54 ET6005.73
11:00 ET8005.725
11:03 ET4005.735
11:07 ET1005.735
11:09 ET5005.735
11:12 ET33005.7669
11:16 ET1005.76
11:18 ET32005.755
11:20 ET1005.755
11:21 ET5005.765
11:23 ET1005.765
11:25 ET15165.775
11:27 ET9105.76
11:30 ET96055.8
11:32 ET1005.805
11:34 ET4005.81
11:36 ET4005.81
11:38 ET13605.795
11:39 ET30065.79
11:41 ET4005.78
11:43 ET3005.775
11:45 ET3045.785
11:48 ET61895.79
11:50 ET7005.8
11:52 ET10535.79
11:54 ET4005.8
11:56 ET44345.83
11:57 ET1005.85
11:59 ET5005.8443
12:03 ET55555.825
12:06 ET1005.83
12:08 ET6955.83
12:10 ET17005.8
12:12 ET9005.8028
12:14 ET1005.8
12:15 ET1005.79
12:17 ET3005.79
12:19 ET2005.78
12:21 ET6005.79
12:28 ET1005.79
12:30 ET2005.78
12:32 ET1005.775
12:35 ET1005.77
12:37 ET11005.78
12:44 ET4005.8
12:46 ET5005.79
12:48 ET13005.78
12:50 ET9515.78
12:51 ET4005.79
12:57 ET1005.795
01:00 ET1005.79
01:04 ET5005.78
01:06 ET2005.785
01:08 ET15005.79
01:09 ET13005.79
01:11 ET2005.79
01:15 ET1005.795
01:20 ET3005.78
01:26 ET4005.79
01:27 ET2005.795
01:29 ET2005.79
01:31 ET3005.79
01:33 ET2005.79
01:38 ET10425.795
01:40 ET1005.8
01:42 ET2005.79
01:45 ET12355.78
01:47 ET11095.79
01:49 ET6005.78
01:51 ET7005.76
01:54 ET104945.76
01:56 ET24005.76
01:58 ET12475.74
02:00 ET9005.77
02:02 ET4005.75
02:03 ET7405.74
02:05 ET6005.74
02:07 ET7005.75
02:09 ET2785.76
02:12 ET16445.79
02:14 ET14005.78
02:16 ET1005.78
02:18 ET7705.779
02:20 ET2005.77
02:21 ET8005.78
02:23 ET4005.775
02:27 ET8435.775
02:30 ET4815.77
02:32 ET30485.72
02:34 ET8005.7036
02:36 ET17005.72
02:38 ET17455.75
02:39 ET14655.795
02:41 ET4025.83
02:43 ET5005.85
02:45 ET12005.84
02:48 ET31505.88
02:52 ET11985.8975
02:54 ET34255.9
02:56 ET27455.88
02:57 ET11375.87
02:59 ET9005.86
03:01 ET5325.88
03:03 ET26765.91
03:06 ET10005.93
03:08 ET3005.92
03:10 ET7005.94
03:12 ET9005.94
03:14 ET15005.9271
03:15 ET26795.91
03:17 ET8005.895
03:19 ET28705.89
03:21 ET121195.905
03:24 ET35055.9
03:26 ET37465.91
03:28 ET3005.91
03:30 ET43305.925
03:32 ET28005.93
03:33 ET10005.95
03:35 ET30115.98
03:37 ET44055.98
03:39 ET11605.97
03:42 ET6145.97
03:44 ET105255.99
03:46 ET19005.97
03:48 ET16105.96
03:50 ET18005.95
03:51 ET13745.91
03:53 ET42965.925
03:55 ET38145.91
03:57 ET68845.93
04:00 ET43915.95
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMGNX
MacroGenics Inc
354.7M
-1.9x
---
United StatesHRTX
Heron Therapeutics Inc
322.2M
-1.3x
---
United StatesNGM
NGM Biopharmaceuticals Inc
428.2M
-2.7x
---
United StatesSELB
Selecta Biosciences Inc
270.9M
5.5x
---
United StatesSTRO
Sutro Biopharma Inc
416.1M
-2.8x
---
United StatesTARS
Tarsus Pharmaceuticals Inc
420.4M
-5.6x
---
As of 2023-02-01

Company Information

MacroGenics, Inc. is a biopharmaceutical company that is focused on developing and commercializing antibody-based therapeutics for the treatment of cancer. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is MGC018, an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. It is also developing enoblituzumab, an Fc-optimized monoclonal antibody (mAb) that targets B7-H3 and molecules that target programmed cell death protein 1 (PD-1), a protein that is important in the regulation of the immune system's response to cancer. Its clinical pipeline includes two bispecific DART product candidates that co-engage both PD-1 and lymphocyte-activation gene 3 (LAG-3) (tebotelimab), and PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (lorigerlimab). In addition, it is also developing MGD024.

Contact Information

Headquarters
9704 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
301-251-5172
Fax
301-251-5321

Executives

Independent Chairman of the Board
William Heiden
President, Chief Executive Officer, Director
Scott Koenig
Chief Financial Officer, Senior Vice President, Corporate Secretary
James Karrels
Chief Operating Officer
Eric Risser
Senior Vice President - Research, Chief Scientific Officer
Ezio Bonvini

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$354.7M
Revenue (TTM)
$93.0M
Shares Outstanding
61.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.95
EPS
$-3.11
Book Value
$3.91
P/E Ratio
-1.9x
Price/Sales (TTM)
3.8
Price/Cash Flow (TTM)
---
Operating Margin
-206.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.